Tiabendazole

Tiabendazole

Clinical data
Trade names	Mintezol, others
AHFS/Drugs.com	International Drug Names
Pregnancy category	AU: B3
Routes of administration	By mouth, topical
ATC code	D01AC06 (WHO) P02CA02 (WHO) QP52AC10 (WHO)
Legal status
Legal status	AU: S4 (Prescription only) In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability	Сmax 1–2 hours (oral administration)
Metabolism	GI tract
Elimination half-life	8 hours
Excretion	Urine (90%)
Identifiers
IUPAC name 4-(1H-1,3-Benzodiazol-2-yl)-1,3-thiazole
CAS Number	148-79-8 Y
PubChem CID	5430
IUPHAR/BPS	7304
DrugBank	DB00730 N
ChemSpider	5237 N
UNII	N1Q45E87DT
KEGG	D00372 Y
ChEMBL	ChEMBL625 N
NIAID ChemDB	007903
CompTox Dashboard (EPA)	DTXSID0021337
ECHA InfoCard	100.005.206
Chemical and physical data
Formula	C10H7N3S
Molar mass	201.25 g·mol−1
3D model (JSmol)	Interactive image
Density	1.103 g/cm3
Melting point	293 to 305 °C (559 to 581 °F)
SMILES [nH]1c2ccccc2nc1c3cscn3
InChI InChI=1S/C10H7N3S/c1-2-4-8-7(3-1)12-10(13-8)9-5-14-6-11-9/h1-6H,(H,12,13) N Key:WJCNZQLZVWNLKY-UHFFFAOYSA-N N
NY (what is this?)  (verify)

Tiabendazole (INN, BAN), also known as thiabendazole (AAN, USAN) or TBZ and the trade names Mintezol, Tresaderm, and Arbotect, is a preservative,^[1] an antifungal agent, and an antiparasitic agent.